Krsnaa Diagnostics spurts ~4% on posting 117% yoy growth in PAT

30 May 2022 , 11:17 AM

Krsnaa Diagnostics Ltd., one of India’s fastest-growing diagnostic service providers, both in radiology and pathology, announced its results for the year ending March 31, 2022.

The company achieved revenue from operations of Rs455 crore for FY22, up by 14.90% yoy as compared to the previous year.

It reported an EBITDA of Rs133 crore in FY22 as compared to the previous financial year, registering a growth of 39.90% yoy. Company’s Profit After Tax stood for the current financial year at Rs68 crore, up by a whopping 117.10% yoy.

EBITDA margins improved significantly to 29% during FY22 as compared to 24% in FY21, the sharp improvement in EBITDA margin was driven by a higher number of tests, contribution from the core business, and increased operational efficiencies.

The company’s Core business of radiology and pathology registered a revenue increase of 70.1% yoy, which was partially offset by a decline of 78.4% in Covid-19 revenues. The core business contribution was 93% whereas the Covid-19 business contributed 7% to the total revenues in FY22.

At around 11.21 AM, Krsnaa Diagnostics was trading at Rs542.05, up by Rs19.20 or 3.67% as compared to previous close of Rs522.85 on NSE. The scrip opened at Rs549 and touched intraday high and low of Rs549.35 and Rs533 respectively.